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Abstract
Obesity is a serious international health problem that increases the risk of several diet-related chronic diseases. The genetic
factors predisposing to obesity are little understood. Rcan2 was originally identified as a thyroid hormone-responsive gene.
In the mouse, two splicing variants that harbor distinct tissue-specific expression patterns have been identified: Rcan2-3 is
expressed predominately in the brain, whereas Rcan2-1 is expressed in the brain and other tissues such as the heart and
skeletal muscle. Here, we show that Rcan2 plays an important role in the development of age- and diet-induced obesity. We
found that although the loss of Rcan2 function in mice slowed growth in the first few weeks after birth, it also significantly
ameliorated age- and diet-induced obesity in the mice by causing a reduction in food intake rather than increased energy
expenditure. Rcan2 expression was most prominent in the ventromedial, dorsomedial and paraventricular hypothalamic
nuclei governing energy balance. Fasting and refeeding experiment showed that only Rcan2-3 mRNA expression is up-
regulated in the hypothalamus by fasting, and loss of Rcan2 significantly attenuates the hyperphagic response to starvation.
Using double-mutant (Lep
ob/ob Rcan2
2/2) mice, we were also able to demonstrate that Rcan2 and leptin regulate body
weight through different pathways. Our findings indicate that there may be an Rcan2-dependent mechanism which
regulates food intake and promotes weight gain through a leptin-independent pathway. This study provides novel
information on the control of body weight in mice and should improve our understanding of the mechanisms of obesity in
humans.
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Introduction
Obesity has reached epidemic proportions globally over the past
several decades, and now poses a major risk for serious diet-related
chronic diseases, such as type 2 diabetes and cardiovascular
diseases [1–3]. It is widely accepted that obesity is a result of the
interaction of genetic and environmental factors [4]. Epidemio-
logical evidence has clearly shown direct linkage between
overnutrition and obesity [5,6]. In rodents, high-fat diets also
have been demonstrated to induce obesity [7,8]. However, the
genetic factors linking obesity to overnutrion are poorly under-
stood.
RCAN2 (also known as ZAKI-4, Dscr1l1, MCIP2 or Calcipressin 2)
[9] was originally identified as a thyroid hormone (T3)-responsive
gene in cultured human skin fibroblasts [10] and subsequently
reported to function as a regulator of calcineurin [11,12]. In the
mouse, two splicing variants that harbor distinct tissue-specific
expression patterns have been identified: Rcan2-3 (formerly named
ZAKI-4a) is expressed predominately in the brain, whereas Rcan2-1
(formerly named ZAKI-4b) is expressed in the brain and other
tissues such as the heart and skeletal muscle [13].
To determine the function of Rcan2 in the whole organism, we
generated Rcan2-null (Rcan2
2/2) mice by targeted disruption of the
exon 4 which is used by Rcan2-1 and Rcan2-3. We fortuitously
found that Rcan2
2/2 mice showed reduced body weight and white
adipose mass compared to the control mice, especially, they
showed a significantly reduced rate of weight gain on the high-fat
diet. We analyzed food intake, energy expenditure and expression
of genes involved in the control of energy metabolism. The results
showed that Rcan2 regulates food intake and body weight through
the mechanism independent from leptin pathway. These findings
provide novel insights into the mechanisms of body weight
regulation and should have important implications to studies on
obesity in human populations.
Results and Discussion
To evaluate the physiological role of Rcan2, we generated
Rcan2
2/2 mice in which a LacZ/Neo cassette replaced exon 4
(Figure 1A). Northern blotting analyses confirmed the absence of
Rcan2-1 and Rcan2-3 in Rcan2
2/2 mice (Figure 1B). Although an
earlier study did not report any obvious differences between
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2/2 mice and their littermates on a 129Sv/B6 mixed genetic
background [14], we found that on the B6 background alone,
Rcan2
2/2 mice had significantly lower body weights than their
littermates.
The postnatal weights of mice produced by intercrossing
Rcan2
+/2 heterozygotes were measured. At birth, there were no
significant differences between genotypes (data not shown).
However, by 3 weeks of age, Rcan2
2/2 mice were smaller than
their littermates and continued to show slower growth up to 5
weeks of age (Figure 2A and 2B). There was little evidence of
genotype-related variation in growth rates from 5 to 10 weeks of
age but, later, the body weights of Rcan2
2/2 males increased more
slowly. As a consequence, at 22 weeks of age, Rcan2
2/2 males
weighed about 16.7% less than wild-type males (25.460.7 g in
Rcan2
2/2 mice versus 30.560.9 g in wild type; p,0.0001)
(Figure 2A). By comparison, Rcan2
2/2 females were only 8%
smaller than their wild-type littermates at 22 weeks of age
(20.260.3 g in Rcan2
2/2 mice versus 22.060.4 g in wild type;
p,0.001) (Figure 2B). Nine-month-old Rcan2
2/2 males were
approximately 20% smaller than their wild-type littermates
(27.260.7 g in Rcan2
2/2 mice versus 34.161.1 g in wild type;
p,0.0001) (Figure 2C and 2D). Measurement of tibia lengths
showed those of Rcan2
2/2 mice were only 2% shorter than the
wild-type (18.0960.06 mm in Rcan2
2/2 mice versus 18.456
0.03 mm in wild type; p,0.0001) (Figure 2E). However, white
adipose tissues (WAT) were markedly reduced in Rcan2
2/2 mice
at about 60% of the wild-type (Figure 2F). The weight differences
continually increased as the animals aged. At 18 months of age,
Rcan2
2/2 males weighed about 27.7% less than wild-type males
(31.661.1 g in Rcan2
2/2 mice versus 43.761.4 g in wild type;
p,0.0001, n=6 in each group) (data not shown). These data
indicate that loss of Rcan2 function slowed the rate of growth in
the initial weeks after birth, and significantly ameliorated, at least
in male mice, age-related obesity.
Since Rcan2
2/2 mice gained less weight on the normal chow
diet, we sought to determine their response to diet-induced obesity.
When Rcan2
2/2 mice were challenged with a high-fat diet from 10
weeks of age, they showed a significantly reduced rate of weight
Figure 1. Generation of Rcan2-deficient mice. (A) Schematic description of the strategy used to generate the mutant Rcan2 allele. LacZ,
promoter-less LacZ gene; Neo
r, neomycin resistance gene; DT-A, diphtheria toxin gene; pBS, pBluescript II vector. (B) Representative Northern blots.
Brain total RNA was probed with Rcan2-1 or Rcan2-3 specific sequences.
doi:10.1371/journal.pone.0014605.g001
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littermates (Figure 3A and 3B). At the end of the experiment,
Rcan2
2/2 males weighed an average of 10 g less than wild-type
males (31.360.8 g in Rcan2
2/2 mice versus 41.361.1 g in wild
type; p,0.0001) (Figure 3A), compared to 5.1 g on the normal
chow diet (25.460.7 g in Rcan2
2/2 mice versus 30.560.9 g in
wild type; p,0.0001) (Figure 2A). The difference in response to
the high-fat diet was also pronounced in female mice (Figure 3B).
The Rcan2
2/2 mice had significantly reduced WAT weights after
the high-fat diet compared to wild-type mice (Figure 3C). Also,
livers of Rcan2
2/2 mice weighed on average approximately 1.2 g
less than those of wild-type mice (Figure 3D) and did not exhibit
the typical feature of fatty liver observed in wild-type mice (data
not shown). Because diet-induced obesity always causes insulin
resistance and glucose intolerance, we also evaluated whether
Rcan2
2/2 mice showed any changes among them. An intraper-
itoneal glucose tolerance test showed that Rcan2
2/2 mice can clear
glucose more efficiently than wild-type controls (Figure 3E). When
mice were intraperitoneally injected with a fixed dose of insulin,
Rcan2
2/2 mice showed a much more prolonged and pronounced
hypoglycemia than wild-type mice, indicating an increase of
insulin sensitivity (Figure 3F).
Recently, it has been demonstrated that Rps6kb1
2/2 mice
manifested slow growth in the first several weeks after birth [15],
and were resistant to age- and high-fat diet induced obesity [16].
These phenotypes are similar to those of Rcan2
2/2 mice.
Rps6kb1
2/2 mice appear to be protected against obesity due to
the up-regulation of genes such as uncoupling protein 1 (Ucp1),
Ucp3, Ppar-c co-activator-a (Pgc1-a) and peroxisome proliferator-
activated receptor b/d (Ppar-b/d) that control the oxidative
phosphorylation pathway [16]. To explore whether a similar
pattern of gene up-regulation is responsible for the Rcan2
2/2
phenotype, we analyzed the expression levels of these genes in
skeletal muscle and brown adipose tissue. No significant
differences were found between Rcan2
2/2 and wild-type mice
(Figure S1A and S1B). These results indicate that the mechanism
for protection against obesity differs between Rcan2
2/2 and
Rps6kb1
2/2 mice.
Figure2.ReducedbodyweightsinRcan2
2/2 mice. (A, B) Growth curves of male (A) and female (B) mice fed a normal chow diet. Sixteen Rcan2
+/+,
29 Rcan2
+/2, and 15 Rcan2
2/2 males were analyzed from postnatal week 3 to week 10, and 9, 16, and 7, respectively, after postnatal week 10.
Eighteen Rcan2
+/+,3 4Rcan2
+/2, and 23 Rcan2
2/2 females were analyzed from postnatal week 3 to week 10, and 11, 19, and 17, respectively, after
postnatal week 10. **: P,0.001, ***: P,0.0001 (vs Rcan2
+/+); +:P ,0.05, ++:P ,0.005 (vs Rcan2
+/2). (C) Representative examples of 9-month-old
Rcan2
+/+ and Rcan2
2/2 males. (D) Mean body weights of ten 9-month-old Rcan2
+/+ and Rcan2
2/2 males. (E) Mean tibia lengths of eight 9-month-old
Rcan2
+/+ and Rcan2
2/2 males. (F) Mean weight of epididymal and retroperitoneal white adipose tissue (EWAT and RWAT, respectively) in ten
9-month-old Rcan2
+/+ and Rcan2
2/2 males. All values are given as mean 6 s.e.m. ***: P,0.0001. Filled circles/columns indicate Rcan2
+/+ mice; open
circles/columns, Rcan2
2/2 mice.
doi:10.1371/journal.pone.0014605.g002
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used the CLAMS system to measure energy expenditure. Since
lean mass is the major determinant of energy expenditure [17–19],
weight-matched 9-week-old males were selected for the analyses.
No significant differences were observed in oxygen consumption
(VO2) (Figure 4A) or carbon dioxide production (data not shown),
but Rcan2
2/2 mice showed a slight decrease in cumulative
physical activity during the night period (Figure 4B). These
analyses indicated that Rcan2
2/2 mice had similar energy
expenditure as weight-matched controls. We then monitored food
intake and body weights in male mice on the normal chow diet
from postnatal week 13 to week 15, the period in which differences
in body weight gain between Rcan2
2/2 and wild-type male mice
were prominent. During this period, Rcan2
2/2 male mice ingested
about 8.5% less food (64.5761.22 g in Rcan2
2/2 mice versus
70.5461.41 g in wild type; p,0.005) (Figure 4C) and gained 0.7 g
less body weight than wild-type controls (0.7060.17 g in Rcan2
2/2
mice versus 1.4060.21 g in wild type; p,0.05) (Figure 4D).
Therefore, differential food intake contributes, at least in part, to
the differential weight gain. Similar measurements were obtained
for male mice on the high-fat diet from postnatal week 11 to week
13. During this period, Rcan2
2/2 mice ingested about 10.3% less
food (44.4961.14 g in Rcan2
2/2 mice versus 49.5860.91 g in wild
type; p,0.02) (Figure 4E) and gained 2.2 g less body weight than
controls (2.0060.24 g in Rcan2
2/2 mice versus 4.2060.42 g in
wild type; p,0.005) (Figure 4F). The similar reduction of food
intake in Rcan2
2/2 mice on the normal chow or high-fat diet
suggests that Rcan2 might regulate food intake in a uniform
manner regardless of its quality. We excluded the possibility of
malabsorption in Rcan2
2/2 mice by calculating apparent absorp-
tion efficiency. The analysis showed that loss of Rcan2 had no
significant effect on food absorption either on the normal chow
diet (75.161.0% in Rcan2
2/2 mice versus 76.060.4% in wild
type; p=0.32) (Figure 4G) or on the high-fat diet (88.560.4% in
Rcan2
2/2 mice versus 88.960.4% in wild type; p=0.38)
(Figure 4H).
Taken together, our data suggested that the reduced body
weight of Rcan2
2/2 mice was attributable to reduced food intake.
Food intake is mainly controlled by regulatory centers in the
hypothalamus [20–22]. We examined expression of Rcan2 in the
hypothalamus by using X-gal staining. Analysis of stained sections
of brain tissue showed that Rcan2 was widely expressed, and was
particularly prominent in hypothalamic nuclei such as the
ventromedial (VMH), dorsomedial (DMH), and paraventricular
(PVH) hypothalamic nuclei (Figure 5A–5D). Mice with lesions in
the VMH and PVH show hyperphagia and obesity suggesting
these regions are involved in regulation of feeding and body weight
[23,24]. Thus, the distribution patterns of Rcan2 suggest that it
Figure 3. Amelioration of high-fat diet-induced obesity in Rcan2
2/2 mice. (A, B) Growth curves of 9 Rcan2
+/+ and 10 Rcan2
2/2 males (A) and
5 Rcan2
+/+ and 5 Rcan2
2/2 females (B) mice fed on a high-fat diet for 12 weeks. ***: P,0.0001. (C) Mean weight of epididymal and retroperitoneal
white adipose tissue (EWAT and RWAT, respectively) in four Rcan2
+/+ and Rcan2
2/2 males fed on a high-fat diet for 12 weeks. (D) Mean weight of liver
in four Rcan2
+/+ and Rcan2
2/2 males fed on a high-fat diet for 12 weeks. (E) Glucose tolerance test. n=6 in each group. (F) Insulin tolerance test. n=6
in each group. All values are given as mean 6 s.e.m. *: P,0.05; **: P,0.01. Filled circles/columns indicate Rcan2
+/+ mice; open circles/columns,
Rcan2
2/2 mice.
doi:10.1371/journal.pone.0014605.g003
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has been reported as a regulator of calcineurin [11,12], its
distribution in the brain did not coincide with that of calcineurin
[25], which is highly expressed in the hippocampus [26,27]. The
non-overlapping distribution suggests that hypothalamic Rcan2
may have calcineurin-unrelated functions. To address this
question, we measured hypothalamic calcineurin activity in
Rcan2
2/2 mice and controls and found no significant difference
between the two groups (Figure S2).
Given the clear distribution of Rcan2 in the hypothalamus, we
investigated whether hypothalamic Rcan2 mRNA expression is
regulated in wild-type mice. From six weeks of age, both Rcan2-1
and Rcan2-3 mRNAs were expressed at a relatively constant level
in the fed state as the animals aged either on the normal chow diet
or on the high-fat diet (Figure 6A). However, we found that
24 hours of fasting specifically increased expression of Rcan2-3
mRNA, the splicing variant of which is predominately expressed in
the brain by about 40% in the hypothalamus (Figure 6B).
Considering that mice respond to 24 hours of fasting with
compensatory hyperphagia, we then examined whether the
increased Rcan2-3 expression is involved in the hyperphagic
response. Rcan2
2/2 mice began to show significant difference in
cumulative food intake from wild-type mice after 4-hours
refeeding (p=0.01). After 24-hours refeeding, Rcan2
2/2 mice
ingested about 17.1% less food than wild-type mice (4.2260.25 g
in Rcan2
2/2 mice versus 5.0960.28 g in wild type; p,0.05)
(Figure 6C). Since in the ad lib fed state, Rcan2
2/2 mice ingested
about 10% less food than wild-type controls (Figure 4C and 4E),
these data suggest that up-regulation of Rcan2-3 expression might
be involved in the hyperphagic response to fasting. Weight loss was
comparable between Rcan2
2/2 and wild-type mice after 24 hours
of fasting (12.4160.80% in Rcan2
2/2 mice versus 11.9160.48%
in wild type; p=0.57) (Figure 6D).
We next investigated whether lack of Rcan2 might affect
expression of the hypothalamic neuropeptides proopiomelanocor-
tin (POMC), agouti-related peptide (AgRP), neuropeptide Y
(NPY), prepro-orexin, and melanin-concentrating hormone
(MCH) that are considered to be regulators of feeding and energy
balance [20–22]. Expression of these neuropeptides in the
hypothalamus did not differ between Rcan2
2/2 and control mice
in the fed or fasted states (Figure S3).
Currently, body weight and adipose mass are considered to be
tightly regulated by homeostatic mechanisms in which leptin, an
adipocyte secreted hormone [28], provides a major feedback signal
to the hypothalamus [20–22]. Leptin circulates at levels propor-
tional to body fat content [29,30] and acts on hypothalamic
neurons that express the neuropeptides. Leptin regulates food
intake and energy expenditure through these neurons depending
on the status of the adipose tissues [20–22]. Fasting decreases
leptin levels in the body, which leads to a hyperphagic response by
increasing the expression of neuropeptides (e.g. AgRP/NPY,
prepro-orexin and MCH) in these neurons. Since Rcan2-3
expression was found to be up-regulated in the hypothalamus by
fasting, we investigated whether the up-regulation of Rcan2-3
expression is caused by the low leptin levels. Previous studies
showed that hypothalamic neuropeptides, such as NPY and MCH
which are up-regulated by fasting, are also over-expressed in
leptin-dificient (Lep
ob/ob) mice [31,32]. We then examined whether
Rcan2-3 is over-expressed in Lep
ob/ob mice. No significant difference
was found between Lep
ob/ob and wild-type mice (Figure S4). This
analysis thus indicates that Rcan2-3 expression is not regulated by
leptin.
Figure 4. Parameters of energy expenditure and food intake. (A, B) Oxygen consumption (VO2) (A) and physical activity (B) in weight-matched
9-week-old Rcan2
+/+ and Rcan2
2/2 males fed the normal chow diet (NCD). Four males of each genotype were analyzed. (C, D) Cumulative food intake
(C) and increased body weight (D) measured from postnatal week 13 to week 15 in 6 Rcan2
+/+ and 6 Rcan2
2/2 males fed the NCD. (E, F) Cumulative
food intake (E) and increased body weight (F) measured from postnatal week 11 to week 13 in 3 Rcan2
+/+ and 4 Rcan2
2/2 males fed the high-fat diet
(HFD). (G, H) Apparent absorption efficiency (AAE) measured in mice fed either the NCD (G) or the HFD (H). Three Rcan2
+/+ and 4 Rcan2
2/2 males were
used for each experiment. All values are given as mean 6 s.e.m. *: P,0.05; **: P,0.01. Filled columns indicate Rcan2
+/+ mice; open columns, Rcan2
2/2
mice.
doi:10.1371/journal.pone.0014605.g004
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weight via a leptin-independent pathway, we introduced the Rcan2
mutation into Lep
ob/ob mice. Double-mutant (Lep
ob/ob Rcan2
2/2)
mice were generated by intercrossing doubly heterozygous mice.
The weights of animals fed a normal chow diet were monitored
from 3 weeks of age. Double-mutant males showed lower body
weights than Lep
ob/ob males from 4 weeks (Figure 7A). In females,
significant differences were evident by 5 weeks (Figure 7B). At 20
weeks of age, double-mutant males weighed about 13.5% less than
Lep
ob/ob males (50.361.14 g in double-mutant mice versus
58.260.4 g in Lep
ob/ob mice; p,0.0001) (Figure 7A and 7C). This
weight reduction was reflected in decreased weights of WAT and
liver in the double-mutant males (Figure 7D). In females, the weight
differences between double-mutant and Lep
ob/ob mice slightly
increased as the animals aged (Figure 7B), similar to the growth
patterns seen in Rcan2
2/2 and wild-type females fed the normal
chow diet (Figure 2B). Moreover, as shown in Table S1, when we
analyzed how the loss of Rcan2 (or leptin) affected body weight by
calculating the ratios of body weights of age-matched mice (Data
from Figure 2A, 2B, 7A and 7B), we found that absence of Rcan2 on
the wild-type or Lep
ob/ob genetic background reduced body weight to
a similar extent, while loss of leptin on the wild-type or Rcan2
2/2
genetic background increased body weight to a similar extent. This
analysis indicates that Rcan2 and leptin regulate body weight
through different pathways.
Taken together, our current work has firmly established an
important role of Rcan2 in the regulation of food intake and body
weight: firstly, the studies of Rcan2
2/2 mice showed that loss of
Rcan2 function significantly ameliorates age- and high-fat diet-
induced obesity by causing a reduction of food intake; secondly,
analysis of expression of Rcan2 showed prominent expression in
hypothalamic nuclei governing food intake and body weight;
thirdly, fasting and refeeding experiment showed that Rcan2-3
expression is up-regulated by fasting, not by leptin, in the
hypothalamus, and loss of Rcan2 significantly attenuates the
hyperphagic response to starvation; finally and most importantly,
using double-mutant (Lep
ob/ob Rcan2
2/2) mice, we were able to
demonstrate that Rcan2 and leptin regulate body weight through
different pathways. Thus, our data indicate that there may be an
Rcan2-dependent mechanism that regulates food intake and
promotes weight gain through a leptin-independent pathway.
These findings provide novel insights into the mechanisms of body
weight regulation and should have important implications to
studies on obesity in human population. The molecular basis of
this putative pathway remains to be clarified. It is noteworthy that
although Rcan2 was originally identified as a T3-responsive gene
[10], it was recently reported that T3 only regulates the expression
of Rcan2-3 [33], the splicing variant that is predominately
expressed in the brain. However, studies of some seasonal animal
species showed that hypothalamic T3 availability acts as a
gatekeeper for seasonal control of body weight caused by
alteration of food intake rather than energy expenditure [34,35],
although the downstream targets of T3 were not identified. In this
study, we found that only Rcan2-3 expression is up-regulated in the
hypothalamus by fasting, which might be involved in the
hyperphagic response to starvation. Future studies using in situ
hybridization or PCR-analyses combined with micro-dissection
technique will address the question of whether Rcan2-3 rather than
Rcan2-1 is the molecule that is predominantly expressed in the
hypothalamic nuclei and regulates food intake and body weight.
Materials and Methods
Generation of Rcan2
2/2 mice
The targeting vector was constructed by replacing the sequence
corresponding to exon 4, which is used by Rcan2-1 and Rcan2-3, with
the LacZ/Neo cassette (Fig. S1a). In addition, a diphtheria toxin A
expression cassette for negative selection was attached to the 3’ end of
the Rcan2 sequence in the targeting vector. The linearized vector was
electroporated into 129Sv embryonic stem cells. A clone that had
undergone the expected recombination was injected into blastocysts
from C57BL/6J (B6) mice to obtain chimeric mice. The chimeric
Figure 5. Distribution of Rcan2 in the hypothalamus. (A-D) X-gal staining of brain coronal sections (A–C) and sagittal sections (D) revealed that
Rcan2 was highly expressed in the dorsomedial (DMH), ventromedial (VMH) and paraventricular (PVH) hypothalamic nuclei. (E) X-gal staining of wild-
type controls.
doi:10.1371/journal.pone.0014605.g005
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mutation onto a B6 genetic background, we used the mice produced
in the latter cross to initiate repeated backcrosses with B6 mice to
produce a B6-Rcan2
+/2 partial congenic strain. The Rcan2 locus is
located on chromosome 17. To limit the extent of the 129Sv-derived
region around the targeted locus, we adopted a modified ‘‘speed
congenesis’’ strategy from the fourth (N4) to sixth (N6) backcrosses.
Briefly, the heterozygous offspring of the N4 generation were
screened with polymorphic markers on chromosome 17 to select the
mouse with the shortest 129Sv-derived chromosomal segment. The
selectedN4mousewasthenbackcrossedwithB6 micetoproduce N5
offspring, and the same screen was repeated and again at the N6
generation. At the N6 generation, a mouse that contained an
approximately10 Mb129Sv-derivedchromosomalsegmentbetween
markers D17Mit24 and D17Mit108 was selected for later backcrosses.
The backcross was continued up to 14 generations. All the
experimental work was conducted with mice that derived from the
intercross of N7 to N14 B6-Rcan2
+/2 partial congenic mice.
Genotyping was carried out by PCR analysis of DNA extracted
from tail tissue. The primers used for genotyping are listed in
Table S2.
Animal experiments
Mice were maintained in a specific pathogen-free barrier facility
at the Research Institute of Environmental Medicine, Nagoya
University, under conditions of constant temperature (23uC), a 12-h
light/12-h dark cycle, and ad lib access to normal chow diet (4%
total calories derived from fat, 2,835 kcalkg
21) (Labo MR Breeder,
Nihon Nosan Co., Kanagawa, Japan) or high-fat diet (56.7% total
calories derived from fat, 5,076 kcalkg
21) (High-Fat Diet 32, Clea
Figure 6. Expression of Rcan2 mRNA in the hypothalamus and its involvement in the hyperphagic responses. (A) Expression of
hypothalamic Rcan2-1 and Rcan2-3 mRNAs in the ad lib fed state. Total RNA was isolated from hypothalami of 6-week-old wild-type mice or 9-month-
old wild-type mice that was ad lib fed with the normal chow diet (NCD), or from hypothalami of wild-type mice that had been fed with the high-fat
diet (HFD) for 5 months. The RNA was used for quantitative real-time PCR analysis using primers specific for Rcan2-1, Rcan2-3 and b–actin (internal
standard). mRNA expression levels are expressed relative to those of 6-week-old mice. NCD-6W indicates 6-week-old mice fed with the NCD; NCD-9
mon, 9-month-old mice fed with the NCD; HFD-5 mon, wild-type mice fed with the HFD for 5 months. n=5 in each group (B) Expression of
hypothalamic Rcan2-1 and Rcan2-3 mRNAs in the fasted state. Total RNA was isolated from hypothalami of wild-type male that were allowed to feed
ad lib or were fasted for 24 h. The RNA was used for quantitative real-time PCR analysis using primers specific for Rcan2-1, Rcan2-3 and b–actin
(internal standard). mRNA expression levels are expressed relative to those of ad lib fed wild-type mice. Data were expressed as the mean of three
independent experiments. Thirty-one ad lib fed wild-type mice and 30 fasted wild-type mice were used in this analysis. Red columns indicate the
mRNA expression levels in the ad lib fed state; blue columns, the mRNA expression levels in the fasted state. (C) Cumulative food intake in response
to 24-h fasting. Six wild-type males (28.9060.67 g) and six Rcan2
2/2 males (24.7860.81 g) were analyzed. (D) Body weight reduction after 24-h
fasting and 24-h refeeding. Six males of each genotype were analyzed. All values are given as mean 6 s.e.m. *: P,0.05; **: P=0.01; ***: P,0.0001.
Filled circles/columns indicate Rcan2
+/+ mice; open circles/columns, Rcan2
2/2 mice.
doi:10.1371/journal.pone.0014605.g006
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experiments were approved by the ethical committee for animal
experiments of the institute, in accordance with the Guidelines for
Animal Experimentation of the Japanese Association for Labora-
tory Animal Science. Mice were weaned at postnatal day 21 (P21),
and housed with 2,4 littermates of the same gender per cage. Body
weight was measured between 16:00 and 18:00 h once per week.
To generate Lep
ob/ob mice lacking Rcan2, N10 B6-Rcan2
+/2 mice
and Lep
ob/+ mice were crossed to produce the double heterozygote
Lep
ob/+ Rcan2
+/2. These mice were intercrossed to produce double
homozygotes. Genotyping of Lep alleles was carried out by PCR
analysis with the primers listed in Table S2.
Food intake and fecal output measurement
Rcan2
2/2 and wild-type male mice were housed individually in
cages with a steel screen for at least 10 days before measurement of
food intake was started. Consumption of normal chow diet (or
high-fat diet) and body weight were then measured for 3 weeks. To
estimate food consumption, the food in each cage dispenser plus
food that was spilled on the floor of the cage was weighed. Stools
were collected every 24 h, dried for 2 days and then weighed.
Apparent absorption efficiency (AAE) was calculated using the
following equation:
AAE % ðÞ ~
Dry food intake(g){Dry stool mass(g)
Dry food intake(g)
To examine the hyperphagic response to 24-hours fasting, the
mice used for normal chow diet food intake measurement were
selected for the analyses. After food intake measurement was
terminated, the mice were weighed, and food was removed at
09:30 AM. Twenty four hours later, the mice were weighed and
then given a weighted amount of normal chow diet, and the food
intake was measured at 2, 4, 6, 10 and 24 h after refeeding. The
body weight was also measured after the refeeding.
Energy expenditure
Oxygen consumption and physical activity were measured using a
Comprehensive Laboratory Animal Monitoring System (CLAMS,
Figure 7. Reduced body weights in Lep
ob/ob Rcan2
2/2 double-mutant mice. (A, B) Growth curves of male (A) and female (B) Lep
ob/ob and
double-mutant mice fed the normal chow diet. Eleven Lep
ob/ob and 14 double-mutant males were measured from postnatal week 3 to week 10, and 7
and 9, respectively, after postnatal week 10. Eleven Lep
ob/ob and 13 double-mutant females were measured. *: P,0.05, **: P,0.01, ***: P,0.0001. (C)
Appearance of 20-week-old Lep
ob/ob and double-mutant male mice. (D) Weights of epididymal and retroperitoneal white adipose tissue (EWAT and
RWAT, respectively) and of liver in 6 Lep
ob/ob and 6 double-mutant males. All values are given as mean 6 s.e.m. **: P,0.005; ***: P,0.0001. Filled
circles/columns indicate Lep
ob/ob mice; open circles/columns, double-mutant mice.
doi:10.1371/journal.pone.0014605.g007
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were acclimatized for 60 h before measurements commenced.
Glucose and insulin tolerance test
Glucose tolerance tests were performed on 15-h fasted mice.
Animals were injected intra-peritoneally with D-glucose (15%
solution; 1.5 g/kg of body weight), and blood glucose values were
determined at 0, 30, 60, 90, and 150 min post-injection. Insulin
tolerance tests were performed on 3-h fasted animals. Blood
glucose values were measured immediately before and at 15, 30,
45 and 60 min after intra-peritoneal injection of porcine insulin
(0.75 U/kg of body weight). Tail blood was taken and glucose
levels were determined using a Medisafe glucose meter (TER-
UMO, Tokyo, Japan).
X-gal staining
Rcan2
2/2 mice were anesthetized with Nembutal and transcar-
dially perfused with 4% paraformaldehyde in 100 mM PBS for
10 min. Brains were dissected and 500 mm sections were prepared
using brain matrices (Aster Industries, Pittsburgh, Pennsylvania,
USA). The sections were fixed with 4% PFA in 100 mM PBS and
2 mM MgCl2 (pH 7.4) for 1 hour at 4uC, and then washed
3610 min with PBS containing 0.1% Triton X-100 at room
temperature. Staining was carried out at 37uC in PBS that
contained 5 mM potassium ferricyanide, 5 mM potassium ferro-
cynide, 2 mM MgCl2, and 1 mg/ml X-gal.
Real-time quantative RT-PCR
Total RNA was extracted from tissue samples using TriZol
reagent (Invitrogen Japan, Tokyo, Japan). cDNA was synthesized
from total RNA with a ReverTra AceH qPCR RT kit (Toyobo,
Osaka, Japan) and random hexamer primers. Fluorescence-based
real-time quantitative RT-PCR was carried out using the Power
SYBRH Green PCR kit and the ABI Prism 7000 Sequence
Detection System (Applied Biosystems, Japan). Relative levels of
mRNA were normalized against b-actin, then averaged and
expressed as means 6 s.e.m. The sequences of the primers used
for quantitative PCR are listed in Table S2.
Calcineurin phosphatase activity assay
Hypothalami were collected from 5-month-old male mice and
lysed in calcineurin assay buffer (BioMol, Plymouth Meeting, PA).
The Quantizyme Assay System AK-816 was used with 5 mgo f
protein according to the manufacturer’s protocol. Calcineurin
phosphatase activity was measured spectrophotometrically by
detecting free phosphate released from the calcineurin-specific RII
phosphopeptide.
Statistical analysis
Data are expressed as means 6 s.e.m. Two-tailed Student’s t
tests or one-way analysis of variance (ANOVA) were used to
identify statistically significant differences (P,0.05).
Supporting Information
Table S1 The ratios of mean body weights in age-matched
mutant and wild-type mice
Found at: doi:10.1371/journal.pone.0014605.s001 (0.05 MB
DOC)
Table S2 Primers used for mouse genotyping and quantitative
real-time PCR
Found at: doi:10.1371/journal.pone.0014605.s002 (0.04 MB
DOC)
Figure S1 Expression of oxidative phosphorylation-related
genes. (A) Expression of oxidative phosphorylation-related genes
in muscle. (B) Expression of oxidative phosphorylation-related
genes in brown adipose tissue. Total RNA was isolated from
muscle and BAT of 4-month-old males fed the normal chow diet
and subjected to quantitative real-time PCR analysis using specific
primers. mRNA expression levels are expressed relative to those of
wild-type mice. Eight Rcan2+/+ and 9 Rcan22/2 males were
analyzed. All values are given as mean 6 s.e.m. Filled columns
indicate Rcan2+/+ mice; open columns, Rcan22/2 mice.
Found at: doi:10.1371/journal.pone.0014605.s003 (0.20 MB TIF)
Figure S2 Hypothalamic calcineurin activity in mice allowed to
feed ad lib. Calcineurin activity in Rcan22/2 mice is expressed
relative to that of Rcan2+/+ mice. Three males of each genotype
were analyzed. All values are given as mean 6 s.e.m. Filled
columns indicate Rcan2+/+ mice; open columns indicate
Rcan22/2 mice.
Found at: doi:10.1371/journal.pone.0014605.s004 (0.09 MB TIF)
Figure S3 Expression of neuropeptide mRNAs in the hypothal-
amus. Total RNA was isolated from the hypothalami of 3-month-
old male mice that were allowed to feed ad lib or were fasted for
24 h. The RNA was used for quantitative real-time PCR using
primers specific for AgRP, NPY, POMC, MCH, prepro-orexin
and b-actin (internal standard). Neuropeptide expression levels are
expressed relative to those of ad lib fed wild-type mice. All values
are given as mean 6 s.e.m. Filled columns indicate Rcan2+/+
mice; open columns, Rcan22/2 mice. n = 6 in each group. All
values are given as mean 6 s.e.m.
Found at: doi:10.1371/journal.pone.0014605.s005 (0.21 MB TIF)
Figure S4 Expression of hypothalamic Rcan2-1 and Rcan2-3
mRNAs in the Lepob/ob mice. Total RNA was isolated from
hypothalami of ad lib fed wild type or Lepob/ob male mice and
subjected to quantitative real-time PCR analysis using primers
specific for the Rcan2-1, Rcan2-3, NPY and b-actin (internal
standard) genes. mRNA expression levels are expressed relative to
those of ad lib fed wild type mice. Filled columns indicate wild type
mice; open columns, Lepob/ob mice. n =5 in each group. All
values are given as mean 6 s.e.m. *: P,0.02.
Found at: doi:10.1371/journal.pone.0014605.s006 (0.14 MB TIF)
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